Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.75    0.01 (0.57%)
Bid:
1.60
Ask:
1.75
Spread: 0.15 (9.375%)
Market Cap: £35.11m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Director/PDMR Shareholding

1 Aug 2023 16:15

RNS Number : 9615H
Quadrise PLC
01 August 2023
 

1 August 2023

 

Quadrise plc

(the "Company" and together with its subsidiaries the "Group" or "Quadrise") 

 

Director/PDMR Shareholding

 

Quadrise announces that, on 1 August 2023, Philip Hill, Chief Operating Officer, sold 160,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at 1.166 pence per Ordinary Share and subsequently repurchased 160,000 Ordinary Shares at 1.178 pence per Ordinary Share to be held in an ISA.

 

Following the transactions, Mr Hill's beneficial holding remains 160,000 Ordinary Shares, representing approximately 0.01 per cent of the Company's issued share capital.

 

The notification below, made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

 

 

For further information contact:

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Philip Hill

 

 

2

Reason for the notification

 

 

a)

Position/status

PDMR (Chief Operating Officer)

 

 

b)

Initial notification /Amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

Name

Quadrise PLC

 

 

b)

LEI

213800HN2ETG5476U328

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

Ordinary shares of 1 pence each

Identification code

ISIN: GB00B11DDB67

 

 

b)

Nature of the transaction

Sale of Ordinary Shares

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.0117

160,000

d)

 

Aggregated information

 

- Aggregated volume

N/A - single transaction 

 

- Price

N/A - single transaction 

 

e)

Date of the transaction

1 August 2023 

 

f)

Place of the transaction

Outside of a trading venue

 

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

Name

Philip Hill

 

 

2

Reason for the notification

 

 

a)

Position/status

PDMR (Chief Operating Officer)

 

 

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

Name

Quadrise PLC

 

 

b)

LEI

213800HN2ETG5476U328

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

Ordinary shares of 1 pence each

Identification code

ISIN: GB00B11DDB67

 

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.0118

160,000

d)

 

Aggregated information

 

- Aggregated volume

N/A - single transaction 

 

- Price

N/A - single transaction 

 

e)

Date of the transaction

1 August 2023 

 

f)

Place of the transaction

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUPGRUPWGAG
Date   Source Headline
2nd Aug 20247:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.